BACKGROUND: Risk stratification is essential for the clinical decision-making process in patients undergoing revascularization of the unprotected left main coronary artery (ULMCA), since the optimal revascularization strategy still remains subject of ongoing debate. OBJECTIVES: To assess the prognostic value of angiographic versus clinical characteristics for the prediction of major adverse cardiac events (MACE) and to develop a combined risk model. METHODS: In 115 patients, who were followed up for MACE after ULMCA stenting, SYNTAX score and EuroSCORE have been calculated for a combined risk model. RESULTS: Whereas the SYNTAX score was not able to predict MACE at 1 year (32.8 ± 11.7 vs. 29.1 ± 12.2, P = 0.13), the logistic EuroSCORE was significantly increased in these patients suffering a MACE at 1 year [11.9 (4.4/22.6) vs. 4.8 (2.3/14.6)%, P = 0.007]. With ROC curve validated cut-off values, the combination of EuroSCORE (>7.5%) and SYNTAX score (>25) provided incremental predictive value for risk stratification of ULMCA patients (AUC 0.71, 95% CI 0.62-0.79, P < 0.001). This combined risk model was associated with the rate of cardiac mortality (P = 0.04), non-fatal myocardial infarction (P = 0.005), and target lesion revascularization (P = 0.04) and was superior to the SYNTAX score alone (P = 0.03). High risk patients had a 7.1-fold higher risk for MACE (HR 7.1. 95% CI 2.1-24.1, P = 0.002) after 1 year. CONCLUSIONS: For adequate risk assessment in ULMCA patients, consideration of both comorbidities and coronary anatomic complexity, is essential. A combination of angiographic and clinical risk scores improves the prognostic value for the prediction of 1-year MACE risk and is superior to stand-alone scores.
BACKGROUND: Risk stratification is essential for the clinical decision-making process in patients undergoing revascularization of the unprotected left main coronary artery (ULMCA), since the optimal revascularization strategy still remains subject of ongoing debate. OBJECTIVES: To assess the prognostic value of angiographic versus clinical characteristics for the prediction of major adverse cardiac events (MACE) and to develop a combined risk model. METHODS: In 115 patients, who were followed up for MACE after ULMCA stenting, SYNTAX score and EuroSCORE have been calculated for a combined risk model. RESULTS: Whereas the SYNTAX score was not able to predict MACE at 1 year (32.8 ± 11.7 vs. 29.1 ± 12.2, P = 0.13), the logistic EuroSCORE was significantly increased in these patients suffering a MACE at 1 year [11.9 (4.4/22.6) vs. 4.8 (2.3/14.6)%, P = 0.007]. With ROC curve validated cut-off values, the combination of EuroSCORE (>7.5%) and SYNTAX score (>25) provided incremental predictive value for risk stratification of ULMCA patients (AUC 0.71, 95% CI 0.62-0.79, P < 0.001). This combined risk model was associated with the rate of cardiac mortality (P = 0.04), non-fatal myocardial infarction (P = 0.005), and target lesion revascularization (P = 0.04) and was superior to the SYNTAX score alone (P = 0.03). High risk patients had a 7.1-fold higher risk for MACE (HR 7.1. 95% CI 2.1-24.1, P = 0.002) after 1 year. CONCLUSIONS: For adequate risk assessment in ULMCA patients, consideration of both comorbidities and coronary anatomic complexity, is essential. A combination of angiographic and clinical risk scores improves the prognostic value for the prediction of 1-year MACE risk and is superior to stand-alone scores.
Authors: F Roques; S A Nashef; P Michel; E Gauducheau; C de Vincentiis; E Baudet; J Cortina; M David; A Faichney; F Gabrielle; E Gams; A Harjula; M T Jones; P P Pintor; R Salamon; L Thulin Journal: Eur J Cardiothorac Surg Date: 1999-06 Impact factor: 4.191
Authors: Davide Capodanno; Anna Caggegi; Marco Miano; Glauco Cincotta; Fabio Dipasqua; Giuseppe Giacchi; Piera Capranzano; Gianpaolo Ussia; Maria Elena Di Salvo; Alessio La Manna; Corrado Tamburino Journal: JACC Cardiovasc Interv Date: 2011-03 Impact factor: 11.195
Authors: Scot Garg; Giovanna Sarno; Chrysafios Girasis; Pascal Vranckx; Ton de Vries; Michael Swart; Marco Bressers; Hector M Garcia-Garcia; Gerrit-Anne van Es; Lorenz Räber; Gianluca Campo; Marco Valgimigli; Keith D Dawkins; Stephan Windecker; Patrick W Serruys Journal: JACC Cardiovasc Interv Date: 2011-06 Impact factor: 11.195
Authors: Scot Garg; Gregg W Stone; Arie-Peter Kappetein; Joseph F Sabik; Charles Simonton; Patrick W Serruys Journal: JACC Cardiovasc Interv Date: 2010-09 Impact factor: 11.195
Authors: Patrick W Serruys; Yoshinobu Onuma; Scot Garg; Giovanna Sarno; Marcel van den Brand; Arie-Pieter Kappetein; Nic Van Dyck; Michael Mack; David Holmes; Ted Feldman; Marie-Claude Morice; Antonio Colombo; Eric Bass; Katrin Leadley; Keith D Dawkins; Gerrit-Anne van Es; Marie-Angèle M Morel; Friedrich W Mohr Journal: EuroIntervention Date: 2009-05 Impact factor: 6.534
Authors: Christoph Sinning; Elvin Zengin; Christoph Waldeyer; Moritz Seiffert; Renate B Schnabel; Edith Lubos; Tanja Zeller; Christoph Bickel; Stefan Blankenberg; Peter M Clemmensen; Dirk Westermann Journal: Clin Res Cardiol Date: 2016-06-30 Impact factor: 5.460
Authors: Christoph Sinning; Lars Lillpopp; Sebastian Appelbaum; Francisco Ojeda; Tanja Zeller; Renate Schnabel; Edith Lubos; Annika Jagodzinski; Till Keller; Thomas Munzel; Christoph Bickel; Stefan Blankenberg Journal: Clin Res Cardiol Date: 2013-03-23 Impact factor: 5.460
Authors: Sérgio Madeira; Luís Raposo; João Brito; Ricardo Rodrigues; Pedro Gonçalves; Rui Teles; Henrique Gabriel; Francisco Machado; Manuel Almeida; Miguel Mendes Journal: Arq Bras Cardiol Date: 2016-03-22 Impact factor: 2.000